TR200101160T2 - İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler. - Google Patents

İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.

Info

Publication number
TR200101160T2
TR200101160T2 TR2001/01160T TR200101160T TR200101160T2 TR 200101160 T2 TR200101160 T2 TR 200101160T2 TR 2001/01160 T TR2001/01160 T TR 2001/01160T TR 200101160 T TR200101160 T TR 200101160T TR 200101160 T2 TR200101160 T2 TR 200101160T2
Authority
TR
Turkey
Prior art keywords
substituted
esters derived
new esters
phenylcyclohexyl
compounds
Prior art date
Application number
TR2001/01160T
Other languages
English (en)
Inventor
Carlos Del Castillo Nieto Juan
Huguet Clotet Joan
De Ramon Amat Elisabet
Chalaux Freixa Maria
Mourelle Mancini Marisabel
Original Assignee
Vita-Invest, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita-Invest, S.A. filed Critical Vita-Invest, S.A.
Publication of TR200101160T2 publication Critical patent/TR200101160T2/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Tramadol'den elde edilen ikame fenil-sikloheksil bilesimlerinden elde edilen yeni esterler, bunlarin elde edilme islemi ve analjezik özelliklere sahip olan ilacin hazirlanmasinda bunlarin kullanimi. Genel formülün (I) bu yeni bilesenleri daha yüksek bir analjezik aktiviteye, daha az toksiteye ve daha uzun bir etkinlik zamanina sahiptir.
TR2001/01160T 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler. TR200101160T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802329A ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.

Publications (1)

Publication Number Publication Date
TR200101160T2 true TR200101160T2 (tr) 2002-01-21

Family

ID=8305698

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2002/00415T TR200200415T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR2002/00416T TR200200416T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR2001/01160T TR200101160T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2002/00415T TR200200415T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR2002/00416T TR200200416T2 (tr) 1998-11-06 1999-11-04 İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.

Country Status (39)

Country Link
US (1) US6455585B1 (tr)
EP (3) EP1219623B1 (tr)
JP (1) JP2002529442A (tr)
KR (1) KR100453613B1 (tr)
CN (1) CN1176902C (tr)
AP (1) AP1222A (tr)
AT (3) ATE257817T1 (tr)
AU (1) AU755681B2 (tr)
BG (1) BG105556A (tr)
BR (1) BR9915727A (tr)
CA (1) CA2349245A1 (tr)
CR (1) CR6368A (tr)
CU (1) CU23006A3 (tr)
CZ (1) CZ20011500A3 (tr)
DE (3) DE69914229T2 (tr)
DK (3) DK1127871T3 (tr)
EA (1) EA003742B1 (tr)
EE (1) EE200100246A (tr)
ES (4) ES2141688B1 (tr)
GE (1) GEP20033116B (tr)
HR (1) HRP20010412B1 (tr)
HU (1) HUP0104218A3 (tr)
ID (1) ID29017A (tr)
IL (1) IL142592A0 (tr)
IS (1) IS5934A (tr)
MA (1) MA26765A1 (tr)
MX (1) MXPA01004432A (tr)
NO (1) NO20012234D0 (tr)
NZ (1) NZ511739A (tr)
OA (1) OA11672A (tr)
PL (1) PL347492A1 (tr)
PT (3) PT1219623E (tr)
SI (3) SI1219594T1 (tr)
SK (1) SK284068B6 (tr)
TR (3) TR200200415T2 (tr)
UA (1) UA59477C2 (tr)
WO (1) WO2000027799A1 (tr)
YU (1) YU29601A (tr)
ZA (1) ZA200104026B (tr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
AU2003264311A1 (en) * 2002-08-28 2004-04-08 Jin Wang Oral formulations of ibuprofen and tramadol, methods and preparation thereof
HUE033042T2 (en) 2002-11-22 2017-11-28 Gruenenthal Gmbh Combination of selected analgesics with COX II inhibitors
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
NZ586792A (en) 2008-01-25 2012-09-28 Gruenenthal Chemie Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces
RU2508092C2 (ru) 2008-05-09 2014-02-27 Грюненталь Гмбх Способ получения твердой лекарственной формы, в частности таблетки для фармацевтического применения, и способ получения прекурсора твердой лекарственной формы, в частности таблетки
WO2011009604A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
EP2383255A1 (en) 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
PL2611426T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie
RU2607499C2 (ru) 2010-09-02 2017-01-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
PT2736497T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
EP2819656A1 (en) 2012-02-28 2015-01-07 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
MX362357B (es) 2012-04-18 2019-01-14 Gruenenthal Gmbh Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
WO2013168005A2 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP3003283A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
WO2015004245A1 (en) 2013-07-12 2015-01-15 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
ATE257817T1 (de) 2004-01-15
EP1219623A1 (en) 2002-07-03
EP1219623B1 (en) 2004-01-14
SI1219594T1 (en) 2004-06-30
CU23006A3 (es) 2004-12-17
DE69911235T2 (de) 2004-07-01
EP1219594A1 (en) 2002-07-03
PT1127871E (pt) 2003-12-31
ES2213732T3 (es) 2004-09-01
YU29601A (sh) 2003-04-30
ATE257837T1 (de) 2004-01-15
DE69914229D1 (de) 2004-02-19
EP1219594B1 (en) 2004-01-14
DE69914231T2 (de) 2004-11-11
HRP20010412A2 (en) 2002-12-31
EA200100476A1 (ru) 2002-02-28
HUP0104218A3 (en) 2002-11-28
HRP20010412B1 (en) 2004-04-30
ID29017A (id) 2001-07-26
NZ511739A (en) 2002-11-26
DK1127871T3 (da) 2003-11-24
DE69911235D1 (de) 2003-10-16
MA26765A1 (fr) 2004-12-20
ZA200104026B (en) 2002-05-17
UA59477C2 (uk) 2003-09-15
NO20012234L (no) 2001-05-04
BG105556A (en) 2001-12-29
ES2213731T3 (es) 2004-09-01
CN1325377A (zh) 2001-12-05
TR200200415T2 (tr) 2002-06-21
EP1127871B1 (en) 2003-09-10
ES2141688B1 (es) 2001-02-01
PT1219623E (pt) 2004-04-30
PT1219594E (pt) 2004-04-30
ATE249418T1 (de) 2003-09-15
BR9915727A (pt) 2001-09-04
SI1219623T1 (en) 2004-06-30
HUP0104218A2 (hu) 2002-03-28
SK284068B6 (sk) 2004-09-08
CA2349245A1 (en) 2000-05-18
DK1219594T3 (da) 2004-04-19
US6455585B1 (en) 2002-09-24
DK1219623T3 (da) 2004-04-19
EE200100246A (et) 2002-12-16
KR100453613B1 (ko) 2004-10-20
AP1222A (en) 2003-11-06
SI1127871T1 (en) 2004-02-29
AU755681B2 (en) 2002-12-19
CN1176902C (zh) 2004-11-24
ES2207298T3 (es) 2004-05-16
OA11672A (en) 2005-01-12
ES2141688A1 (es) 2000-05-16
EP1127871A1 (en) 2001-08-29
MXPA01004432A (es) 2002-09-18
SK5842001A3 (en) 2001-12-03
EA003742B1 (ru) 2003-08-28
DE69914229T2 (de) 2004-12-09
CR6368A (es) 2002-04-08
KR20010080942A (ko) 2001-08-25
NO20012234D0 (no) 2001-05-04
JP2002529442A (ja) 2002-09-10
CZ20011500A3 (cs) 2001-09-12
IS5934A (is) 2001-05-03
AU1047300A (en) 2000-05-29
IL142592A0 (en) 2002-03-10
DE69914231D1 (de) 2004-02-19
GEP20033116B (en) 2003-11-25
PL347492A1 (en) 2002-04-08
WO2000027799A1 (es) 2000-05-18
TR200200416T2 (tr) 2003-01-21

Similar Documents

Publication Publication Date Title
TR200101160T2 (tr) İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
TR199700803T1 (tr) Trombin-inhibitörleri olarak yeni dipeptidik amidinler.
PT841929E (pt) Quinolonas e sua utilizacao terapeutica
TR199901653T2 (tr) Fitalazinonlar.
TR200102800T2 (tr) Yeni bileşikler.
TR200003333T2 (tr) Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler
CA2260337A1 (en) Therapeutic agents
DE60012188D1 (de) Fungizide
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
ATE167476T1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
BR9611175A (pt) Compostos ou suas composições e uso dos mesmo
ATE238800T1 (de) Verwendung von squalamin zur herstellung eines arzneimittels zur inhibierung von nhe
FI972628A (fi) Uudet sulfonamidit
TR199901674T2 (tr)
PT1506185E (pt) Compostos novos e sua utilizacao
TR200100075T2 (tr) 2-Kuinolon ihtiva eden farmasötik bileşimler
ID22042A (id) Benzonaftiridin sebagai pengobatan cabang tenggorokan
FR2355808A1 (fr) Anilides iodes utilisables comme agents de contraste
ATE495187T1 (de) Dalda-analoge und ihre verwendung
MXPA03002911A (es) Compuestos quimicos.
GEP20022654B (en) Indazole Amide Compounds As Serotoninergic Agents
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
SE9804212D0 (sv) Compounds
ATE297903T1 (de) Substituierte phenyluracile
IL132599A0 (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use